208 related articles for article (PubMed ID: 23633409)
1. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients.
Beard CJ; Travis LB; Chen MH; Arvold ND; Nguyen PL; Martin NE; Kuban DA; Ng AK; Hoffman KE
Cancer; 2013 Aug; 119(15):2771-7. PubMed ID: 23633409
[TBL] [Abstract][Full Text] [Related]
2. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
4. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
Powles T; Robinson D; Shamash J; Moller H; Tranter N; Oliver T
Ann Oncol; 2008 Mar; 19(3):443-7. PubMed ID: 18048383
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: a population-based analysis.
Ahmed KA; Wilder RB
Cancer Epidemiol; 2014 Apr; 38(2):124-8. PubMed ID: 24613492
[TBL] [Abstract][Full Text] [Related]
6. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma.
Horwich A; Fossa SD; Huddart R; Dearnaley DP; Stenning S; Aresu M; Bliss JM; Hall E
Br J Cancer; 2014 Jan; 110(1):256-63. PubMed ID: 24263066
[TBL] [Abstract][Full Text] [Related]
7. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
8. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
[TBL] [Abstract][Full Text] [Related]
9. Noncancer causes of death in survivors of testicular cancer.
Fosså SD; Gilbert E; Dores GM; Chen J; McGlynn KA; Schonfeld S; Storm H; Hall P; Holowaty E; Andersen A; Joensuu H; Andersson M; Kaijser M; Gospodarowicz M; Cohen R; Pukkala E; Travis LB
J Natl Cancer Inst; 2007 Apr; 99(7):533-44. PubMed ID: 17405998
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Pisansky TM; Davis BJ; Choo R
Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
[TBL] [Abstract][Full Text] [Related]
11. Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients.
Ahmed KA; Wilder RB
Int Braz J Urol; 2015; 41(1):78-85. PubMed ID: 25928512
[TBL] [Abstract][Full Text] [Related]
12. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy.
Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264
[TBL] [Abstract][Full Text] [Related]
13. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
14. Mortality and cancer incidence following radiotherapy for seminoma of the testis.
Horwich A; Bell J
Radiother Oncol; 1994 Mar; 30(3):193-8. PubMed ID: 8209001
[TBL] [Abstract][Full Text] [Related]
15. Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends.
Thong AE; Lichtensztajn DY; Almario L; Ingels A; Gomez SL; Gonzalgo ML
J Urol; 2013 Oct; 190(4):1240-4. PubMed ID: 23567749
[TBL] [Abstract][Full Text] [Related]
16. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
Hallemeier CL; Davis BJ; Pisansky TM; Choo R
Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy of testicular seminoma: changes over the past 10 years].
Mirimanoff RO
Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
20. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]